Events & Ideas

Our Work

Prescription Medicines

The 2020 CPDD Membership Survey: A New Approach to Assessing Diversity and Inclusion in Scientific Organizations

Fields S, Henningfield J, Regan T, Correa-Fernandez V, de Dios M, Garcia-Romeu A, Heads A, Hood C, Hudzik T, Moreland A, Skinstad A Advancing equity, inclusion and diversity is vital to increase innovation and the excellence of science as well at its relevance to societal and public health needs. This survey was developed to support… Read More

Prescription Medicines

Results of the 2020 CPDD Membership Survey: We Are More Diverse Than Suggested by Earlier Survey Approaches

Hood C, Garcia-Romeu A, Moreland A, Fields S, Henningfield JE, Correa-Fernandez V, de Dios M, Heads A, Hudzik T, Regan R, Skinstad A. Efforts to advance equity, inclusion, and diversity within CPDD are vital to increasing innovation and excellence in addiction science and relevance to societal and public health needs. This project examines openended responses… Read More

Prescription Medicines

Abuse Potential Related Science and Regulatory Perspectives for Psychedelic Drug Product Development

Jack Henningfield, PhD, Vice President, Research, Health Policy, and Abuse Liability, Pinney Associates Presented as part of the NIH Psilocybin Speaker Series, April 22-June 10, 2021 VISIT THE SPEAKER SERIES WEBSITE

Prescription Medicines

Design and Operational Challenges in Psychedelic Clinical Trials

Marion Coe, PhD, Director, Clinical Development and Postmarketing Surveillance, Pinney Associates Presented as part of the session Hot Topics in Psychedelic Drug Development: From Successful Clinical Trials to Maximizing Benefits in the Post-approval World, May 5, 2021 VISIT THE CONFERENCE WEBSITE

OTC Products

Complexities of planning, developing, and validating a switch opportunity via a regulatory pathway

Bernie Simone, Vice President of Client Strategy and Rx-to-OTC Switch, Pinney Associates Presented at Rx-to-OTC Switch Symposium, Dynamic Global Events, March 15-16, 2021

Dietary Ingredients & Supplements

Social Media Monitoring versus a Consumer Survey to Elucidate Reasons and Patterns of Intake among Kratom Users

Henningfield, J., Barr, M., Wang, D. and Huestis, M. American College of Neuropsychopharmacology, virtual meeting, Poster presented virtually, December 9, 2020.

Dietary Ingredients & Supplements

Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use

Singh D, Brown PN, Cinosi E, Corazza O, Henningfield JE, Garcia-Romeu A, McCurdy CR, McMahon LR, Prozialeck WC, Smith KE, Swogger MT,Veltri C, Walsh Z, Grundmann O Frontiers in Psychiatry, 11:574483, 2020 View publication

Prescription Medicines

Targeting Differences: Strategies to Demonstrate the Benefits of Novel CNS-active Analgesics

Moderator Jack Henningfield, PhD, Vice President, Research, Health Policy, and Abuse Liability, Pinney Associates Panelists David Heal, PhD, DSc, FRSC, FBPhS, Executive Director, DevelRx Ltd. Reginald Fant, PhD, Director, Clinical Pharmacology and Abuse Potential Assessment Judy Ashworth, MD, Vice President, Rx Strategic Services and Chief Medical Officer, Pinney Associates Presented at the 14th Annual Pain… Read More